Core Laboratories, N.V. (CLB) posted solid operational results for the second quarter. The company achieved historical quarterly highs for revenue, while its operating margins increased 300 basis points from the year-earlier level to a record 28%, driven by the successful introduction of new technologies and services, further penetration into additional fields, as well as through higher margin contracts.
We continue to like the company for its leadership position in the reservoir optimization niche, global footprint, and deep portfolio of proprietary products and services, thereby providing it with a very strong leverage to the current oilfield cycle.
Additionally, the company's global footprint and strong existing relationships in all major hydrocarbon-producing regions of the world give it a competitive edge over its peers. We see significant upside in the stock from current levels, particularly following its recent sell off (the stock is down more than 20% in the last few weeks).
During the second quarter, Core generated $39.9 million in free cash flow. Capital expenditures for the period were $8.0 million, up from $5.1 million in the prior year's second quarter. The company expects full year capex to be in the $25 million to $30 million range. At the end of the quarter, the company had $54.6 million in cash.
Our unchanged $155 price objective reflects 2009 P/E and EV/EBITDA multiples of 20.6x and 14.0x, both well within historical trading ranges. Core Labs valuation premium relative to the group is justified given its leading position in the reservoir optimization niche.
Read the full analyst report on CLB
Get real-time market insights and profitable stock recommendations from the team of analysts at Zacks Equity Research. See all todays Analyst Blog entries on Zacks.com.